Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Capricor sets up 2nd DMD approval attempt with ph. 3 win
The results mimic those of prior phase 2 studies, which Capricor used to seek approval of deramiocel last year only to be rejected by the FDA.
Darren Incorvaia
Dec 3, 2025 11:11am
Fierce Pharma
With site 'irregularities,' BMS delays key Cobenfy readout
Dec 3, 2025 10:14am
Pharvaris clocks a pivotal win in race for rapid HAE relief
Dec 3, 2025 9:10am
Muvon flexes muscle cell data to challenge incontinence implants
Dec 3, 2025 8:19am
Analyst deems Janux's stock spiral an 'overreaction'
Dec 2, 2025 11:14am
Imvax takes brain cancer therapy to FDA despite missing primary
Dec 2, 2025 8:00am
